| 产品 |
标题 |
描述 |
| 聚乙二醇化远程可装载脂质体 |
300205S |
聚乙二醇化远程可装载脂质体, aqueous solution |
| 17(S)-HDHA |
900125E |
17(S)-HDHA, Avanti Polar Lipids 900125E, ethanol solution |
| DOBAQ |
850310P |
DOBAQ, Avanti Polar Lipids 850310P, powder |
| Upstate脂混合物 |
790595P |
Upstate脂混合物, Synthetic Phospholipid Blend for PTEN, PDK1, and Akt1/PKBα Assay Kits, contains DOPC/DOPS (1:1, wt%), powder |
| C16 1-磷酸神经酰胺(d18:1/16:0) |
860533P |
C16 1-磷酸神经酰胺(d18:1/16:0), Avanti Polar Lipids 860533P, powder |
| 14:0 Cardiolipin (sodium salt) |
750332C |
14:0 Cardiolipin (sodium salt), 1′,3′-bis[1,2-dimyristoyl-sn-glycero-3-phospho]-glycerol (sodium salt), chloroform |
| Farnesyl-L-cysteine |
700308P |
Farnesyl-L-cysteine, Avanti Polar Lipids |
| 20:1 SM (d18:1/20:1)-d9 |
860742L |
20:1 SM (d18:1/20:1)-d9, Avanti Polar Lipids |
| 17:0 PC |
850360C |
17:0 PC, 1,2-diheptadecanoyl-sn-glycero-3-phosphocholine, chloroform |
| PI (3,4) P2：18:1 |
850153P |
PI (3,4) P2：18:1, 1,2-dioleoyl-sn-glycero-3-phospho-(1′-myo-inositol-3′,4′-bisphosphate) (ammonium salt), powder |
| 14:0 SM (d18:1/14:0) |
860688P |
14:0 SM (d18:1/14:0), Avanti Polar Lipids 860688P, powder |
| 18:3 (Cis) PC |
850395C |
18:3 (Cis) PC, Avanti Polar Lipids 850395C |
| Yeast Extract Polar |
190001C |
Yeast Extract Polar, Avanti Polar Lipids 190001C |
| 18:1 PEG5000 PE |
880230P |
18:1 PEG5000 PE, Avanti Polar Lipids 880230P, powder |
| 18:0 Cy7 PE |
810347C |
18:0 Cy7 PE, Avanti Polar Lipids 810347C |
| 2-OHOA |
791056P |
2-OHOA, 2-hydroxyoleic acid (sodium salt), powder |
| arachidonic acid-d11 |
861810E |
arachidonic acid-d11, Avanti Polar Lipids 861810E, ethanol solution |
| Ursodeoxycholic acid |
700199P |
Ursodeoxycholic acid, powder, Avanti Polar Lipids |
| 18：1（n9）辅酶A |
870719P |
18：1（n9）辅酶A, Avanti Polar Lipids 870719P, powder |
| NBD Sphingosine-1-Phosphate |
810207X |
NBD Sphingosine-1-Phosphate, Avanti Polar Lipids 810207X |
| 22:6 PG |
840492C |
22:6 PG, Avanti Polar Lipids 840492C |
| 15:0 LYSO PG-d5 |
858123L |
15:0 LYSO PG-d5, Avanti Polar Lipids |
| 18:0-16:0(16-Azido) PC |
870133P |
18:0-16:0(16-Azido) PC, Avanti Polar Lipids |
| 16:0 Ptd Ethylene Glycol |
870305P |
16:0 Ptd Ethylene Glycol, Avanti Polar Lipids 870305P, powder |
| C17:1 anandamide |
870431P |
C17:1 anandamide, Avanti Polar Lipids 870431P, powder |
| MAPCHO®-16 |
850337P |
MAPCHO®-16, n-hexadecylphosphocholine, powder |
| 18:1 BMP (R,R) |
857136P |
18:1 BMP (R,R), sn-(1-oleoyl-2-hydroxy)-glycerol-3-phospho-sn-3′-(1′-oleoyl-2′-hydroxy)-glycerol (ammonium salt), powder |
| Control (5mL vial) |
300116S |
Control (5mL vial), Avanti Polar Lipids |
| 18:3 (n3) Coenzyme A |
870732P |
18:3 (n3) Coenzyme A, Avanti Polar Lipids 870732P, powder |
| sphinganine (d17:0) |
860654P |
sphinganine (d17:0), Avanti Polar Lipids 860654P, powder |
| 15:0 LYSO PI-d5 |
850107L |
15:0 LYSO PI-d5, Avanti Polar Lipids |
| 18:1 Ethylene Glycol |
800605C |
18:1 Ethylene Glycol, 1-2-dioleoyl ethylene glycol, chloroform |
| C14 神经酰胺（d18：1/14：0） |
860514P |
C14 神经酰胺（d18：1/14：0）, Avanti Polar Lipids 860514P, powder |
| Ceramide Synthase (CerS5/CerS6) Assay Kit |
640014P |
Ceramide Synthase (CerS5/CerS6) Assay Kit, Avanti Polar Lipids |
| 14:1 (Δ9-Cis) PC |
850346C |
14:1 (Δ9-Cis) PC, 1,2-dimyristoleoyl-sn-glycero-3-phosphocholine, chloroform |
| 5-PAHSA |
900410C |
5-PAHSA, 5-(palmitoyloxy)octadecanoic acid, chloroform |
| 17:0 LYSO PG-d5 |
858130L |
17:0 LYSO PG-d5, Avanti Polar Lipids 858130L-1MG |
| Brain PE |
840022C |
Brain PE, Avanti Polar Lipids 840022C |
| 16:0 TAP |
890870C |
16:0 TAP, Avanti Polar Lipids 890870C |
| 14:0 TAP |
890860P |
14:0 TAP, Avanti Polar Lipids 890860P, powder |
| NBD Sphingosine |
810205P |
NBD Sphingosine, omega(7-nitro-2-1,3-benzoxadiazol-4-yl)(2S,3R,4E)-2-aminooctadec-4-ene-1,3-diol, powder |
| Ent-DOPC |
850856C |
Ent-DOPC, Avanti Polar Lipids |
| 3β-hydroxy-5-cholestenoic acid |
700082P |
3β-hydroxy-5-cholestenoic acid, (25R)-cholest-5-en-26-oic acid, 3β-hydroxy, powder |
| PHAD®-504 |
699810P |
PHAD®-504, Avanti Polar Lipids 699810P, powder |
| 3A-MPLA |
699851P |
3A-MPLA, Avanti Polar Lipids 699851P, powder |
| DOPE-RGD |
870296P |
DOPE-RGD, Avanti Polar Lipids (870296P), powder |
| 24:0 Lyso PC |
855800P |
24:0 Lyso PC, 1-lignoceroyl-2-hydroxy-sn-glycero-3-phosphocholine, powder |
| 14:0 BMP (S,R) |
857131C |
14:0 BMP (S,R), bis(monomyristoylglycero)phosphate (S,R Isomer) (ammonium salt), chloroform |
| β-鼠胆酸 |
700233P |
β-鼠胆酸, Avanti Polar Lipids |
| Yeast Extract Total |
190000C |
Yeast Extract Total, Avanti Polar Lipids 190000C |
| C6-NBD Galactosyl Ceramide |
810220P |
C6-NBD Galactosyl Ceramide, Avanti Polar Lipids 810220P, powder |
| 16:0 PC-d62 |
860355P |
16:0 PC-d62, Avanti Polar Lipids 860355P, powder |
| CER2(d9) |
791660P |
CER2(d9), N-palmitoyl(d9) D-erythro-sphingosine, powder |
| 14:0-18:0 PC |
850446P |
14:0-18:0 PC, 1-myristoyl-2-stearoyl-sn-glycero-3-phosphocholine, powder |
| C15 Glucosyl(β) Ceramide-d7 (d18:1-D7/15:0) |
330729P |
C15 Glucosyl(β) Ceramide-d7 (d18:1-D7/15:0), Avanti Polar Lipids |
| F7-Cholesterol |
700002P |
F7-Cholesterol, Avanti Polar Lipids 700002P, powder |
| 10MAG |
850544O |
10MAG, Avanti Polar Lipids 850544O |
| C6-NBD Ceramide |
810209X |
C6-NBD Ceramide, Avanti Polar Lipids 810209X |
| C18 LPA |
857228P |
C18 LPA, 1-O-octadecyl-2-hydroxy-sn-glycero-3-phosphate (ammonium salt), powder |
| 18:1 Tempo PC |
810608C |
18:1 Tempo PC, Avanti Polar Lipids 810608C |
